Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew Powell

Showing results (41-50 of 59) with videos related to

Pageof 6
Sort By:
Cryobiology|February 14, 2026
Need for harmonized terminology in cryopreservation to support reproducibility, regulation, and translationLakshya Gangwar, Lowell Wolfe, Nikolas Zuchowicz, et al.
The Clinical Neuropsychologist|February 6, 2008
Official position of the military TBI task force on the role of neuropsychology and rehabilitation psychology in the evaluation, management, and research of military veterans with traumatic brain injuryMichael McCrea, Neil Pliskin, Jeffrey Barth, et al.
Gynecologic Oncology|December 17, 2003
Uterine papillary serous carcinoma: comparisons of outcomes in surgical Stage I patients with and without adjuvant therapyWarner K Huh, Matthew Powell, Charles A Leath, et al.
Gynecologic Oncology|April 30, 2022
Molecular profiles of endometrial cancer tumors among Black patientsAnnelise M Wilhite, Yasmine Baca, Joanne Xiu, et al.
Gynecologic Oncology|April 26, 2003
Stage IC adenocarcinoma of the endometrium: survival comparisons of surgically staged patients with and without adjuvant radiation therapyJ Michael Straughn, Warner K Huh, James W Orr, et al.
Gynecologic Oncology|December 4, 2019
A randomized, double-blind, placebo-controlled phase 1b/2 study of ralimetinib, a p38 MAPK inhibitor, plus gemcitabine and carboplatin versus gemcitabine and carboplatin for women with recurrent platinum-sensitive ovarian cancerIgnace Vergote, Florian Heitz, Paul Buderath, et al.
Gynecologic Oncology|March 19, 2017
FGFR2 mutations are associated with poor outcomes in endometrioid endometrial cancer: An NRG Oncology/Gynecologic Oncology Group studyYvette W Jeske, Shamshad Ali, Sara A Byron, et al.
International Journal of Radiation Oncology, Biology, Physics|September 2, 2021
Phase I Trial of Stereotactic MRI-Guided Online Adaptive Radiation Therapy (SMART) for the Treatment of Oligometastatic Ovarian CancerLauren E Henke, Jennifer A Stanley, Clifford Robinson, et al.
Journal of Medicinal Chemistry|August 20, 2021
Mechanistic Investigation of Site-specific DNA Methylating Agents Targeting Breast Cancer CellsLeah L Lowder, Matthew Powell, Sean E Miller, et al.
Gynecologic Oncology|January 6, 2023
Lifestyle intervention in ovarian cancer enhanced survival (LIVES) study (NRG/GOG0225): Recruitment, retention and baseline characteristics of a randomized trial of diet and physical activity in ovarian cancer survivorsCynthia A Thomson, Tracy E Crane, Austin Miller, et al.
Pageof 6

Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
Cryobiology|February 14, 2026
Need for harmonized terminology in cryopreservation to support reproducibility, regulation, and translationLakshya Gangwar, Lowell Wolfe, Nikolas Zuchowicz, et al.
The Clinical Neuropsychologist|February 6, 2008
Official position of the military TBI task force on the role of neuropsychology and rehabilitation psychology in the evaluation, management, and research of military veterans with traumatic brain injuryMichael McCrea, Neil Pliskin, Jeffrey Barth, et al.
Gynecologic Oncology|December 17, 2003
Uterine papillary serous carcinoma: comparisons of outcomes in surgical Stage I patients with and without adjuvant therapyWarner K Huh, Matthew Powell, Charles A Leath, et al.
Gynecologic Oncology|April 30, 2022
Molecular profiles of endometrial cancer tumors among Black patientsAnnelise M Wilhite, Yasmine Baca, Joanne Xiu, et al.
Gynecologic Oncology|April 26, 2003
Stage IC adenocarcinoma of the endometrium: survival comparisons of surgically staged patients with and without adjuvant radiation therapyJ Michael Straughn, Warner K Huh, James W Orr, et al.
Gynecologic Oncology|December 4, 2019
A randomized, double-blind, placebo-controlled phase 1b/2 study of ralimetinib, a p38 MAPK inhibitor, plus gemcitabine and carboplatin versus gemcitabine and carboplatin for women with recurrent platinum-sensitive ovarian cancerIgnace Vergote, Florian Heitz, Paul Buderath, et al.
Gynecologic Oncology|March 19, 2017
FGFR2 mutations are associated with poor outcomes in endometrioid endometrial cancer: An NRG Oncology/Gynecologic Oncology Group studyYvette W Jeske, Shamshad Ali, Sara A Byron, et al.
International Journal of Radiation Oncology, Biology, Physics|September 2, 2021
Phase I Trial of Stereotactic MRI-Guided Online Adaptive Radiation Therapy (SMART) for the Treatment of Oligometastatic Ovarian CancerLauren E Henke, Jennifer A Stanley, Clifford Robinson, et al.
Journal of Medicinal Chemistry|August 20, 2021
Mechanistic Investigation of Site-specific DNA Methylating Agents Targeting Breast Cancer CellsLeah L Lowder, Matthew Powell, Sean E Miller, et al.
Gynecologic Oncology|January 6, 2023
Lifestyle intervention in ovarian cancer enhanced survival (LIVES) study (NRG/GOG0225): Recruitment, retention and baseline characteristics of a randomized trial of diet and physical activity in ovarian cancer survivorsCynthia A Thomson, Tracy E Crane, Austin Miller, et al.
Pageof 6